NXgenPort
Saint Paul
About NXgenPort
NXgenPort Inc is addressing an unmet need in cancer care by remotely monitoring patients between chemotherapy visits with an implanted Smart Port. By measuring cell counts and heart function in vivo, NGP will alert physicians to signs of infection, reduce hospitalizations, and gather important physiological data to improve patient outcomes. There is additional value for cancer researchers and drug delivery stakeholders to remotely monitor a participant's biological response to interventions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: nxgenport.com
- Phone: 6515875440
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nxgenport-197308 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.